Ledger.Open graph →
SEC Form D · filed January 14, 2026

Alveus Therapeutics, Inc

Offering
$110.7M
Sold
$56.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Claudio Nessi · Boston, MADirectorAmeet Nathwani · Philadelphia, PADirectorIvan Gergel · Philadelphia, PADirectorJan Van De Bossche · Philadelphia, PADirectorCarlo De Notaristefani · Philadelphia, PADirectorGarrett Ingram · Philadelphia, PADirectorRaj Kannan · Philadelphia, PAExec · DirectorGregory Parekh · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗